Today: 1 May 2026
Why Zscaler Stock Jumped Today Despite a Wall Street Target Cut
1 May 2026
2 mins read

Why Zscaler Stock Jumped Today Despite a Wall Street Target Cut

NEW YORK, May 1, 2026, 17:02 EDT

Zscaler Inc. jumped roughly 7% Friday, shaking off a new price-target cut from Wall Street. A broader rally in software names pulled the cloud-security stock higher into the session’s end. Shares last changed hands at $139.81, up $9.14, and earlier touched $140.95.

Why does it matter? Investors want to know if software and cybersecurity names—many already battered—have finally bottomed out, or if corporate belt-tightening will keep squeezing growth. Zscaler (ZS) happens to be right in the thick of it: AI-driven security is gaining traction, yet major deals are still running into drawn-out approval cycles at large companies.

Citizens JMP’s Trevor J. Walsh trimmed his price target on Zscaler to $210 from $290 on Friday but left his Buy rating unchanged, TipRanks’ analyst tracker shows. The new target lands about 50% above Friday’s latest price, underscoring that Walsh’s move reflects valuation caution rather than a full step back from the name.

Software names caught a bid. Atlassian surged 29.6% after lifting its full-year outlook, pushing tech to the top of the S&P 500’s sector leaderboard on Friday, according to Reuters. “Cherry on top,” Carson Group’s Ryan Detrick said of the session, as earnings capped off a strong week. Reuters

Zscaler rolled out new product updates this week. In an April 30 GovCloud release, Jose Arvelo Negron, who works as a sales engineering manager at Zscaler, said the company has broadened generative AI prompt controls, introduced AI-driven document classification for roughly 200 additional document types, and made reporting sharper for Zscaler Digital Experience—the company’s platform for monitoring user and app performance.

This is a key point for the public-sector side. GovCloud covers cloud infrastructure tailored for government-level security and compliance. Data loss prevention—DLP for short—refers to technology aimed at catching and stopping sensitive information before it slips out of authorized systems.

Zscaler’s cloud security screens identity, device context, and policy before letting users access apps or data. Reuters says its Zero Trust Exchange shields customers from cyberattacks and data leaks by linking users, devices, and applications securely—no matter where they are. The “zero trust” model doesn’t automatically trust any user or device inside a corporate network. Reuters

Bulls found a reason to stay interested after the company’s latest earnings. Zscaler reported fiscal Q2 revenue up 26% to $815.8 million. Annual recurring revenue—subscription sales likely to recur annually—climbed 25% to $3.36 billion. “Profitability had reached an all-time high,” said Chief Financial Officer Kevin Rubin. Zscaler, Inc.

The risk has hardly disappeared. In its most recent quarterly report, Zscaler noted that customers remain cautious with big-ticket deals, dragging out approval times amid economic uncertainty. The company also flagged that tougher macro or geopolitical factors could weigh on sales, stretch sales cycles, and put pressure on prices.

Competition remains a focus. Back in April, BTIG cut its rating on Zscaler to Neutral from Buy after its checks flagged stiffer rivalry from Cloudflare and Netskope. The firm also noted firewall vendors gaining traction with their own secure-access offerings among current clients.

Friday’s action didn’t really signal a fundamental shift for the company—it felt more like software stocks rallying and Zscaler catching a break after weeks of rough headlines. What’s next? Zscaler still has to prove it can actually convert AI-security buzz and those public-sector updates into stronger organic growth, not only a firmer footing for subscription software stocks.

Stock Market Today

  • Nektar Therapeutics Grants Stock Options and RSUs to New Hires Under Nasdaq Rule
    May 1, 2026, 5:18 PM EDT. Nektar Therapeutics (NASDAQ: NKTR) announced inducement grants to six new employees, awarding 28,450 stock options and 2,950 restricted stock units (RSUs) on April 20, 2026. The grants, under Nektar's 2025 Inducement Plan, comply with Nasdaq Listing Rule 5635(c)(4), allowing equity awards to attract new talent. Stock options are priced at $100.35 per share, matching the closing price that day, with an eight-year term and a four-year vesting schedule. RSUs vest similarly over four years. Nektar, a clinical-stage biotech firm, focuses on autoimmune and inflammatory disease treatments. This move aligns with Nektar's strategy to strengthen its workforce amid ongoing development of its lead candidate, rezpegaldesleukin (REZPEG).

Latest article

Why Zscaler Stock Jumped Today Despite a Wall Street Target Cut

Why Zscaler Stock Jumped Today Despite a Wall Street Target Cut

1 May 2026
Zscaler shares climbed 7% to $139.81 Friday despite a price-target cut by Citizens JMP to $210. The move followed a sector rally after Atlassian raised its forecast. Zscaler reported 26% revenue growth last quarter and expanded AI security features in its GovCloud product. Customers remain cautious on large deals, with longer approval times noted.
Xanadu Quantum Technologies Stock Gets First Big Test as Q1 Results Date Lands

Xanadu Quantum Technologies Stock Gets First Big Test as Q1 Results Date Lands

1 May 2026
Xanadu Quantum Technologies will report first-quarter results May 14, its first earnings since going public last month. Shares closed at $36.12 Friday, up $7.05, with 4.28 million traded. The company posted a $70.7 million net loss in 2025 and raised $302 million via a SPAC merger. Investors will watch the call for updates on spending, cash runway, and funding prospects.
Clorox Stock Slumps After Profit Forecast Cut as Purell Deal and Oil Costs Bite

Clorox Stock Slumps After Profit Forecast Cut as Purell Deal and Oil Costs Bite

1 May 2026
Clorox cut its fiscal 2026 profit forecast, citing higher energy costs, inventory timing, and expenses from its Purell acquisition; shares fell 9.6% to $87.11. The company now expects adjusted EPS of $5.45–$5.65, down from $5.95–$6.30, and organic sales to drop about 9%. Third-quarter sales were flat at $1.67 billion, while gross margin fell to 43.2%.
Xanadu Quantum Technologies Stock Gets First Big Test as Q1 Results Date Lands
Previous Story

Xanadu Quantum Technologies Stock Gets First Big Test as Q1 Results Date Lands

Go toTop